Tada Y, Fujitani T, Yoneyama M
Department of Toxicology, Tokyo Metropolitan Research Laboratory of Public Health, Japan.
Food Chem Toxicol. 1992 Dec;30(12):1021-30. doi: 10.1016/0278-6915(92)90113-y.
The acute toxic effects of thiabendazole [2-(4'-thiazolyl)benzimidazole; TBZ] on the kidneys of ICR mice were investigated. The mice were given 0, 250, 500 or 1000 mg TBZ/kg body weight by gavage (using olive oil as a vehicle), and the kidneys were subjected to pathological examination at 1, 3, 5 or 24 hr after dosing. Gross findings were slight enlargement and the presence of whitish areas (white maculae) in kidneys of treated mice at 3, 5 or 24 hr after dosing. Histological findings were desquamation of degenerated cells in proximal tubules of treated mice at 1 hr. Dilation of proximal, distal and collecting tubules was apparent in treated mice at 3, 5 and 24 hr. TBZ-induced renal injury was reduced by pretreatment with inducers of the microsomal monooxygenase system (sodium phenobarbital, beta-naphthoflavone and 3-methylcholanthrene) and were enhanced by pretreatment with inhibitors of that system (2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride and piperonyl butoxide). The concentration of TBZ in blood at 1 or 5 hr after dosing was lower in mice pretreated with microsomal monooxygenase system inducers and was higher in those pretreated with the inhibitors, than in those given TBZ alone. These results suggest that TBZ-induced renal injury may be attributable to the parent compound rather than its metabolites. Measurement of organic ion uptake into renal slices revealed significant depression of [1-14C]tetraethylammonium bromide (TEA) uptake in treated mice at 1 or 5 hr, whereas uptake of p-[glycyl-2-3H]aminohippurate (PAH) was not depressed at 1 or 5 hr after dosing. The reduction in uptake of TEA is interpreted as the result of competitive suppression of the tubular transport of TEA by TBZ. TBZ-induced renal injury was reduced by organic cation transport inhibitors [N'-methylnicotinamide (NMN) or thiamine] but not by organic anion transport inhibitor [p-(dipropylsulphamyl)benzoic acid probenecid], suggesting that the reduction of TBZ-induced renal injury is the result of competitive suppression of the tubular transport of TBZ by NMN or thiamine.
研究了噻苯达唑[2-(4'-噻唑基)苯并咪唑;TBZ]对ICR小鼠肾脏的急性毒性作用。通过灌胃给小鼠分别给予0、250、500或1000mg TBZ/kg体重(以橄榄油为溶媒),给药后1、3、5或24小时对肾脏进行病理检查。大体检查结果显示,给药后3、5或24小时,处理组小鼠的肾脏略有肿大且存在白色区域(白色斑点)。组织学检查结果显示,给药后1小时,处理组小鼠近端小管中出现变性细胞的脱落。给药后3、5和24小时,处理组小鼠的近端、远端和集合小管明显扩张。用微粒体单加氧酶系统诱导剂(苯巴比妥钠、β-萘黄酮和3-甲基胆蒽)预处理可减轻TBZ诱导的肾损伤,而用该系统抑制剂(盐酸2-二乙氨基乙基-2,2-二苯基戊酸酯和胡椒基丁醚)预处理则会增强肾损伤。与单独给予TBZ的小鼠相比,用微粒体单加氧酶系统诱导剂预处理的小鼠给药后1或5小时血液中TBZ的浓度较低,而用抑制剂预处理的小鼠血液中TBZ的浓度较高。这些结果表明,TBZ诱导的肾损伤可能归因于母体化合物而非其代谢产物。对肾切片中有机离子摄取的测量显示,给药后1或5小时,处理组小鼠对[1-14C]溴化四乙铵(TEA)的摄取显著降低,而给药后1或5小时对p-[甘氨酰-2-3H]氨基马尿酸(PAH)的摄取未降低。TEA摄取的减少被解释为TBZ竞争性抑制TEA肾小管转运的结果。有机阳离子转运抑制剂[N'-甲基烟酰胺(NMN)或硫胺素]可减轻TBZ诱导的肾损伤,但有机阴离子转运抑制剂[p-(二丙基氨磺酰基)苯甲酸丙磺舒]则不能,这表明NMN或硫胺素竞争性抑制TBZ肾小管转运导致了TBZ诱导的肾损伤减轻。